Sfoglia per Autore
Laparoscopic aspiration of ovarian endometriomas : effect with postoperative gonadotropin releasing hormone agonist treatment
1992-07-01 P. Vercellini, N. Vendola, L. Bocciolone, A. Colombo, M.T. Rognoni, G. Bolis
Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas
1993-07-01 P. Vercellini, L. Bocciolone, A. Colombo, N. Vendola, M. Meschia, G. Bolis
Endometriosis and ovarian cancer
1993-07-01 P. Vercellini, F. Parazzini, G. Bolis, S. Carinelli, M. Dindelli, N. Vendola, L. Luchini, P. G. Crosignani
Multifocal endometriosis. A case report
1993-10-01 P. Vercellini, N. Vendola, M. Presti, G. Bolis
Survival of advanced ovarian cancer patients with microscopic partial response after surgery and first-line chemotherapy
1995-06-01 G. Bolis, A. Villa, C. Ferraris, L. Luchini, F. Parazzini
Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy
1996-01-01 G. Bolis, A. Villa, P. Guarnerio, C. Ferraris, N. Gavoni, G. Giardina, M. Melpignano, G. Scarfone, F. Zanaboni, F. Parazzini
Regarding a series of IB bulky cervical cancer treated with neoadjuvant chemotherapy (NACT) and radical hysterectomy and pelvic lymphadenectomy
1996-04-01 G. Bolis, A. Villa, P. Guarnerio, S. Acerboni, F. Parazzini
Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage IB-IIB invasive cervical cancer
1996-10-01 G. Bolis, I. van Zainten-Przybysz, G. Scarfone, F. Zanaboni, C. Scarabelli, S. Tateo, M. Calabrese, F. Parazzini
Is abdomino-pelvic radiation therapy the optimal treatment for completely resected stage I and II high risk ovarian cancer?
1997-01-01 A. Fyles, G. Bolis, C. Ferraris, F. Parazzini, M. Bolla
A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer
1997-04-01 G. Bolis, G. Scarfone, F. Zanaboni, A. Villa, M. Presti, M. Melpignano, C. Ferraris, S. Tateo, P. Guarnerio, A. Gentile, F. Parazzini
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer
1997-05-01 G. Bolis, G. Favalli, S. Danese, F. Zanaboni, G. Mangili, C. Scarabelli, S. Tateo, M. G. Valsecchi, G. Scarfone, G. Richiardi, L. Frigerio, M. Melpignano, A. Villa, F. Parazzini
Case-control study of oestrogen replacement therapy and risk of cervical cancer
1997-07-01 F. Parazzini, C. La Vecchia, E. Negri, S. Franceschi, S. Moroni, L. Chatenoud, G. Bolis
Ovarian cancer risk and history of selected medical conditions linked with female hormones
1997-09-01 F. Parazzini, S. Moroni, C. La Vecchia, E. Negri, D. dal Pino, G. Bolis
Survival and prognostic factors of early ovarian cancer
1998-01-01 A. Villa, F. Parazzini, S. Acerboni, P. Guarnerio, G. Bolis
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol
1998-01-01 R. Silvestrini, M.G. Daidone, S. Veneroni, E. Benini, G. Scarfone, F. Zanaboni, A. Villa, M. Presti, S. Danese, G. Bolis
Determinants of risk of invasive cervical cancer in young women
1998-03-01 F. Parazzini, L. Chatenoud, C. La Vecchia, E. Negri, S. Franceschi, G. Bolis
Topotecan for the treatment of advanced epithelial ovarian cancer : An open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel
1998-10-01 M.A. Bookman, H. Malmström, G. Bolis, A. Gordon, A. Lissoni, J.B. Krebs, S.Z. Fields
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group
1998-12-01 K. Aabo, M. Adams, P. Adnitt, D.S. Alberts, A. Athanazziou, V. Barley, D.R. Bell, U. Bianchi, G. Bolis, M.F. Brady, H.S. Brodovsky, H. Bruckner, M. Buyse, R. Canetta, V. Chylak, C.J. Cohen, N. Colombo, P.F. Conte, D. Crowther, J.H. Edmonson, C. Gennatas, E. Gilbey, M. Gore, D. Guthrie, B.Y. Yeap
A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy
1999-01-01 G. Scarfone, A. Villa, F. Parazzini, C. Sciatta, G. Polverino, G. Bolis
Survival and determinants of response to third-line chemotherapy in sensitive recurrent ovarian cancer patients
1999-01-01 A. Villa, F. Parazzini, G. Scarfone, P. Guarnerio, G. Bolis
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile